The 28th Annual Frederick J. Fischer Pediatric Orthopaedic Lectureship

Friday, April 3, 2026, 7:30 AM - 4:00 PM ET, Frankel Cardiovascular Center, Ann Arbor, MI


AMA PRA Category 1 Credits™ (6.25 hours), Non-Physician Attendance (6.25 hours)

The objective of the Frederick J. Fischer Pediatric Orthopaedic Lectureship is to update Orthopaedic Surgeons, Residents, Fellows, and clinical staff on current techniques and advancements in pediatric orthopaedic surgery

1. Implement recent advances in the diagnosis and management of a variety of Pediatric Orthopaedic conditions, including lower extremity deformity and spinal deformity.

Registration Pricing: $0

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
AMA PRA Category 1 
The University of Michigan Medical School designates this Live Activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement
 
The University of Michigan Medical School is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Activity Coordinator.

Questions? Please contact Olivia Layher.

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

The University of Michigan Medical School adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, or others are required to disclose all relevant financial relationships with ineligible entities. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Friday, April 3, 2026